Clinical Infectious Diseases

Article	Citations
Withdrawn as duplicate: Cover image/text	996
In the Literature	712
Reply to Focosi et al	566
Correction to: Impact of Point-of-Care Testing on the Management of Sexually Transmitted Infections in South Africa: Evidence from the HVTN702 Human Immunodeficiency Virus Vaccine Trial	480
Acute Appendicitis of Unexpected Etiology	312
Correction to: Prevalence of Ocular Complications in Candidemia: Defining the “Battlefield”	238
Response to Rezahosseini and Barrella Harboe	191
Association of Virus Variation and Vaccination Status With Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection	180
Daily Second-generation Integrase Strand Inhibitors and Short-course Tuberculosis Preventive Therapy: What More Do We Need to Know?	164
Don’t Put Off Until Tomorrow What You Can Do Today: Hospital Admissions as an Opportunity to Treat Hepatitis C	162
Use of Carbon Dioxide Monitoring to Assess Ventilation at a National Infectious Diseases Conference	155
Crude Mortality Associated With the Empirical Use of Polymyxins in Septic Patients in a Setting of High Prevalence of Carbapenem-Resistant Gram-negative Bacteria: Retrospective Analysis of a Cohort	154
Historical Advances in Clinical Trial Design and Expanding Representation as the New Frontier for Innovation	141
Correction to: Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Val	137
Pre-exposure Prophylaxis for Transgender People: A Systematic Review	136
Considerations on the Associations Between Antiretroviral Regimen and Changes in Blood Pressure in the D2EFT Study	133
Viral Suppression Trajectories Destabilized After Coronavirus Disease 2019 Among US People With Human Immunodeficiency Virus: An Interrupted Time Series Analysis	131
Modeling Respiratory Syncytial Virus Adult Vaccination in the United States With a Dynamic Transmission Model	130
Because I Hope for Something Better	126
Redefining Complicated Coagulase-Negative Staphylococcal Bacteremia	125
Chronic Aichi Virus Infection As a Cause of Long-Lasting Multiorgan Involvement in Patients With Primary Immune Deficiencies	124
Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical Trial	122
Executive Summary: State-of-the-Art Review: State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms	119
2025 Content Collections from the IDSA Journals	118
International Collaboration to Develop and Harmonize Drug Interaction Guidance for Nirmatrelvir/Ritonavir During COVID-19: Lessons Learned for Future Pandemic Preparedness	117

Collateral Benefits and Methodological Limits of Respiratory Syncytial Virus Immunization for Infant Otitis Media and Antibiotic Use	116
Invasive Listeriosis in Southern Switzerland: A Local Problem That Is Actually Global	106
Does “Toxoplasma Abscess” Properly Describe Brain Lesions Caused by Toxoplasma gondii?	103
A Point-of-Care Prediction Tool for Recurrent Tuberculosis	101
Remdesivir Effectiveness in Reducing the Risk of 30-Day Readmission in Vulnerable Patients Hospitalized for COVID-19: A Retrospective US Cohort Study Using Propensity Scores	101
Two for the Price of One: Can Maternal Influenza Immunization Protect Infants Against Influenza and RSV?	99
Lessons I Learned from Our Soldier	98
Personalized Antibiograms Using Multitask Machine Learning: Toward Mechanistic Understanding and Robust Calibration	95
Blood Culture Time to Positivity and Risk of Infective Endocarditis	91
Comparative Effectiveness of BNT162b2 and mRNA-1273 Booster Dose After BNT162b2 Primary Vaccination Against the Omicron Variants: A Retrospective Cohort Study Using Large-Scale Population-Based Regist	86
A National Retrospective Cohort Study Comparing the Effects of Cefepime Versus Piperacillin-Tazobactam on the Development of Severe Acute Kidney Injury in Patients With Septic Shock	85
Estimating Risk of Guillain-Barré Syndrome in US Medicare-enrolled Older Adults Following Medically Attended Respiratory Syncytial Virus Disease: A Self-controlled Case Series Analysis	83
Transmission of Mycobacterium tuberculosis to Healthcare Personnel Resulting From Contaminated Bone Graft Material, United States, June 2021–August 2022	81
Are Contact Precautions “Essential” for the Prevention of Healthcare-associated Methicillin-Resistant Staphylococcus aureus?	79
Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 201	79
T-SPOT.TB Reactivity in Southern African Children With and Without in Utero Human Immunodeficiency Virus Exposure	76
Diagnostic Uncertainties and Delayed Treatment Protocols Impact Efficacy of FMT for Clostridioides difficile Infection	76
Non- Klebsiella pneumoniae Carbapenemase Attributes of the Newer β-lactam/β-lactamase Inhibitors, Part 2: Burkholderia cepacia	75
IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19 Infections in Immunocompromised Patients	75
You’ve Come a Long Way Baby—but Many Miles Left to Go	74
Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?	71
How Public Health Surveillance Systems Can Contribute to Antimicrobial Resistance Prevention: The Massachusetts Experience	70
Trends in Age-Related Health Outcomes in People with HIV in Spain, 2006–2023	70
Beyond First Impressions	69
Oral Antibiotics for Treatment of Gram-Negative Bacteremia in Solid Organ Transplant Recipients: A Propensity Score Weighted Retrospective Observational Study	68
Development of a Machine Learning Modeling Tool for Predicting HIV Incidence Using Public Health Data From a County in the Southern United States	68
Influenza Hospitalization Burden by Subtype, Age, Comorbidity, and Vaccination Status: 2012–2013 to 2018–2019 Seasons, Quebec, Canada	68
How We Approach Suppressive Antibiotic Therapy Following Debridement, Antibiotics, and Implant Retention for Prosthetic Joint Infection	67
How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus–Associated Cryptococcal Meningitis to High-Income Settings?	66
Retreatment With Nirmatrelvir/Ritonavir Following Return of COVID-19 Symptoms and SARS-CoV-2 Positivity	65
Clinical Presentation, Antimicrobial Resistance, and Treatment Outcomes of Aeromonas Human Infections: A 14-Year Retrospective Study and Comparative Genomics of 2 Isolates From Fatal Cases	64
Revisiting REVISIT: The Case for Ceftazidime/Avibactam Plus Aztreonam	64
Point-of-care Ultrasound in Infectious Diseases: Current Insights and Future Perspectives	64
The Urgent Need to Implement Point-of-Care RNA Testing for Hepatitis C Virus to Support Elimination	63
COVID-19 Antiviral Medication Use Among Pregnant and Recently Pregnant US Outpatients	62
Valve Strands in Patients With Infective Endocarditis	62
Eyes Wide Shut: A Cohort Study Questioning the Role of Fundoscopy in Infective Endocarditis Diagnosis	62
Comparative Performance of Urine Lipoarabinomannan and Urine Xpert MTB/RIF Ultra for Diagnosing Tuberculosis in Adult Inpatients With HIV in East London, South Africa	61
Epigenetic Age Acceleration Markers Are Associated With Physiologic Frailty and All-Cause Mortality in People With Human Immunodeficiency Virus	61
Nocardia farcinica as a Potential Pathogen Associated With a Clinical Subtype of Kikuchi–Fujimoto Disease	60
Sputum and Tongue Swab Molecular Testing for the In-Home Diagnosis of Tuberculosis in Unselected Household Contacts: A Cost and Cost-Effectiveness Analysis	60
Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort Study	60
Superiority Trials in Invasive Aspergillosis: A Harsh Reality Check With the IA-DUET (HOVON502) Trial	59
CD4/CD8 Ratio During Human Immunodeficiency Virus Treatment: Time for Routine Monitoring?	59
Fatal Case of Human B Virus Infection Manifesting With Hemorrhagic Encephalitis and Chorioretinitis	59
Systematic Review of In Vitro Antimicrobial Susceptibility Testing for Bacillus anthracis, 1947–2019	59
Diagnostic Yield of Repeat Blood Cultures and Risk Factors for Bloodstream Infection in Persistent Febrile Neutropenia	58
First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial	58
Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the World	57
Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C	57

A Randomized Trial to Compare Dolutegravir Plus Boosted Darunavir Versus Recommended Standard of Care Antiretroviral Regimens in People With HIV-1, Whose First-line Non-nucleoside Reverse Transcriptas	57
Perspectives on Adherence From the ACTG 5360 MINMON Trial: A Minimum Monitoring Approach With 12 Weeks of Sofosbuvir/Velpatasvir in Chronic Hepatitis C Treatment	56
Characterizing the Rise of Disseminated Gonococcal Infections in California, July 2020–July 2021	56
Post-artesunate Delayed Hemolysis in Patients With Severe Malaria in the United States—April 2019 Through July 2021	55
Is 3 Really What We Need? Relative Effectiveness of Benzathine Penicillin G and Doxycycline Treatment Regimens for Late or Unknown Duration Syphilis in 6 US Jurisdictions, 2016–2021	55
Predictors of Mortality of Streptococcal Bacteremia and the Role of Infectious Diseases Consultation: A Retrospective Cohort Study	54
Correction to: Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination	53
Zinc and Coronavirus Disease 2019	53
Enhanced Tuberculosis Diagnosis With Computer-aided Chest X-ray and Urine Lipoarabinomannan in Adults With HIV Admitted to Hospital (CASTLE Study): A Cluster Randomized Trial	53
Correction to: Higher Plasma Viremia in the Febrile Phase Is Associated With Adverse Dengue Outcomes Irrespective of Infecting Serotype or Host Immune Status: An Analysis of 5642 Vietnamese Cases	53
State-of-the-Art Review: Neurosyphilis	53
Correction to: Coronavirus Disease 2019 Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching Study	53
Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practice	53
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Ill	53
Treatment Completion and Sustained Virologic Response in the Context of Hepatitis C Virus Elimination: Time to Let Go of the Reins?	52
Welcoming Discourse on the Approach for Gram-Negative Bacteremia and Candidemia in Cardiovascular Implantable Electronic Device Infections	52
Investigating Determinants of Pathogenicity of Carbapenemase–Producing Enterobacterales	52
Correction to: Anogenital Human Papillomavirus (HPV) Infection, Seroprevalence, and Risk Factors for HPV Seropositivity Among Sexually Active Men Enrolled in a Global HPV Vaccine Trial	52
Comment on Parameswaran et al's “Increased Stroke Risk Following Herpes Zoster Infection and Protection With Zoster Vaccine”	52
Background HIV Incidence in PURPOSE 1 and 2 PrEP Trials	52
In the Literature	52
A 25-Year-Old Man With Fever, Diarrhea, and Shock	51
Correction to: Transmission of Carbapenem-Resistant Enterobacterales in an Overcrowded Emergency Department: Controlling the Spread to the Hospital	51
Patients Hospitalized With Coronavirus Disease 2019: A Diverse Population	51
Point-of-care Tests for Chlamydia trachomatis and Neisseria gonorrhoeae : Review of the Literature	51
Combined Protection of Vaccination and Nirmatrelvir-Ritonavir Against Hospitalization in Adults With COVID-19	51
The Promise and Peril of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibodies	51
Maintaining the Utility of Coronavirus Disease 2019 Pandemic Severity Surveillance: Evaluation of Trends in Attributable Deaths and Development and Validation of a Measurement Tool	51
Application of Pragmatic Criteria to Assessments of Frailty and Physical Function Among People With HIV	50
Total Antimicrobial Consumption in Doxycycline Postexposure Prophylaxis Cohorts and the Intensity of Screening for Bacterial Sexually Transmitted Infections	49
Innovations in Career Development Through Mentoring in the VTEU/IDCRC Programs	49
Impact of Discontinuation of Contact Precautions on Healthcare-associated Extended Spectrum β-Lactamase-Producing Escherichia coli in a Large Tertiary Ca	48
Herpes Zoster, Vaccine, and Stroke Risk	48
Cardiovascular Disease Risk in Low- and Middle-Income Countries: Better Data for Better Evidence	48
Outcomes Associated With Empiric Azithromycin Use Among Patients Hospitalized With Nonsevere Community-Acquired Pneumonia: Emulation of a Target Trial	48
Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine	48
Selected Industry Highlights From IDWeek 2025	48
Clinical Impact of Pleural Fluid Streptococcus pneumoniae Polymerase Chain Reaction Testing in Children With Complicated Pneumonia	48
From Soil to Skin: An Unexpected Cause of Necrotizing Cellulitis	48
Updated Hepatitis D Seroprevalence Among Hepatitis B Surface Antigen-Positive Persons Aged ≥6 Years in the United States, National Health and Nutrition Examination Survey, 2007‒2018	47
Positive Effects of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following COVID-19 Are Sustained Up to 1 Year After Treatment	47
High Time for Higher-Dose Rifampin	47
Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50–59 Years Compared to ≥60 Years of Age	47
Missed Opportunities for Human Immunodeficiency Virus and Syphilis Co-Testing in Emergency Departments	46
DOLCE: Sweet Success for Dolutegravir/Lamivudine?	46
Effect of Direct-from-blood Bacterial Testing on Antibiotics Administration in Adults Presenting With Acute Infection: A Randomized Trial	46
Narrative Review of Chlamydia trachomatis Culture, Viability Testing, and Sequencing Methods	46
Point-of-Care Urine Tenofovir Drug-Level Feedback Counseling Improves Long-Term Pre-exposure Prophylaxis Adherence for US Men Who Have Sex With Men in Pilot RCT	45
Maternal Antibody Response and Transplacental Transfer Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection or Vaccination in Pregnancy	45
Cephalosporins Versus Non-cephalosporin Antibiotics for Perioperative Prophylaxis in Primary Arthroplasty: A Systematic Review and Meta-Analysis	45
Serum Ammonia Screening and Donor Mollicutes Detection for Hyperammonemia Syndrome Post–Lung Transplantation: A Prospective Observational Study	45
Association of Immunodeficiency and HIV Viremia With Cervical Precancer and Cancer Risk Among Women With HIV in South Africa	45
Risk of Acute Myocardial Infarction Among Patients With Laboratory-Confirmed Invasive Pneumococcal Disease: A Self-Controlled Case Series Study	45
Considerations for the Use of Long-Acting and Extended-Release Agents During Pregnancy and Lactation	44
Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study	44
Implementation of Diagnostic Stewardship to Improve Urinary Tract Infection Antibiotic Use Across 3 Medical Centers	44
Costs Attributable to Clostridioides difficile Infection Based on the Setting of Onset	44
Advancing Access to Diagnostic Tools Essential for Universal Health Coverage and Antimicrobial Resistance Prevention: An Overview of Trials in Sub-Saharan Africa	44
Evaluation and Management of Diabetes-related Foot Infections	44
Increase in False-Positive Fourth-Generation Human Immunodeficiency Virus Tests in Patients With Coronavirus Disease 2019	44
Clinical and Molecular Analyses of Recurrent Gram-Negative Bloodstream Infections	44
Sociodemographic and Occupational Factors Associated With COVID-19 Vaccine and Influenza Vaccine Uptake Among Healthcare Workers, in Albania, 2022–2023: A Multicenter Study	43
Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice	43
State-of-the-Art Review: Anal Cancer Screening in People With HIV	43
Effect of Pitavastatin on Epigenetic Aging Biomarkers in People With HIV: Pilot Substudy of the REPRIEVE Trial	43
Projecting the Potential Clinical and Economic Impact of HIV Prevention Resource Reallocation in Tennessee	43
Side-by-side Comparative Study of the Immunogenicity of the Intramuscular and Intradermal Rabies Post-exposure Prophylaxis Regimens in a Cohort of Suspected Rabies Virus Exposed Individuals	42
Detection-Dependent Classification of Valve Strands: How Much Does Imaging Intensity Drive the “Non-IE” Diagnosis?	42
Markers of Immune Function and Survival Among Cancer Patients With HIV in the United States: A Population-based Registry Linkage Study	42
Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL	42
Comparative Outcomes of Candida auris Bloodstream Infections: A Multicenter Retrospective Case-Control Study	42
Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India	41
CD4/CD8 Ratio Outcome According to the Class of the Third Active Drug in Antiretroviral Therapy Regimens: Results From the Quebec Human Immunodeficiency Virus Cohort Study	41
Invisible Malarias	41
Measles Without Rash During Acute Febrile Illness Surveillance in Tanzania, 2023–2024	41
Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions	41
Zoster Vaccination and Dementia: Interpreting the Signal and Testing the Mechanisms	41
Regional and National Trends in Consumption of Antimicrobials in Pakistan; Pre and Post-COVID (2019–2021)	41
HIV/AIDS and COVID-19: Shared Lessons From 2 Pandemics	41
A 3-Year-Old Girl With a Chest Wall Mass	41

Limited Durability of Improvements in Infection Prevention and Control Practices Following Reactive Interventions Leaves Healthcare Facilities Vulnerable to Ebola Virus Transmission	40
Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study	40
Patterns in Prescribing and Dispensing Influenza Antivirals Among Adults With Influenza Presenting to Urgent Care and Emergency Department Settings: VISION Network, 2023–2024	40
Rabies Despite Postexposure Prophylaxis in High-Burden Settings: Vaccine Failure or Gaps in Healthcare Delivery?	40
Reported Tuberculosis Symptoms: An Inadequate Classifier of Disease State	40
A Systematic Review of Human Challenge Trials, Designs, and Safety	40
Correction to: Duration of Protection After Vaccination Against Yellow Fever: A Systematic Review and Meta-Analysis	39
A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes	39
Beyond Burnout: The Power of Purpose, Partnership, and Serving Others	39
Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper	39
Central Nervous System Antimicrobial Exposure and Proposed Dosing for Anthrax Meningitis	39
The Need for Lenacapavir Compulsory Licences in Ending the HIV Epidemic	39
Discordant Clinical and Microbiological Outcomes Are Associated With Late Clinical Relapse in Clinical Trials for Complicated Urinary Tract Infections	39
Carbapenemase-Producing Enterobacterales in Pets: A New Threat From Veterinary Clinics	38
Virologic Failure and Emergent Integrase Strand Transfer Inhibitor Drug Resistance With Long-Acting Cabotegravir for HIV Treatment: A Meta-analysis	38
Acute Unilateral Vision Loss in a Young Woman	38
A Nonsporulating Sinonasal Culprit	38
HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update	38
Japanese Encephalitis Emergence in Australia: The Potential Population at Risk	38
Cumulative Antibiotic Exposure Is Associated With Ceftriaxone Resistance Among Patients With Urinary Source Gram-negative Bloodstream Infection: A Retrospective Cohort Study	38
Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial	38
High Cytomegalovirus Viral Load Is Associated With 182-Day All-Cause Mortality in Hospitalized People With Human Immunodeficiency Virus	38
Risk of Major Adverse Cardiovascular Events With Dolutegravir Versus Efavirenz-Based Antiretroviral Therapy: Emulated Target Trials Using Routine, De-identified Data From South Africa	38
Improved Consistency of Candida auris Colonization Screening With an Anterior Nares and Hands Composite Sample	38
Immunological Efficacy of Pneumococcal Vaccination Including the 13-Valent Pneumococcal Conjugate Vaccine in Adult Patients With Sickle Cell Disease: Results of the Randomized DREVAC Controlled Trial	37
The Pharmacokinetics/Pharmacodynamic Relationship of Durlobactam in Combination With Sulbactam in In Vitro and In Vivo Infection Model Systems Versus Acinetobacter baumannii-calcoaceticus Compl	37
Effectiveness of Coronavirus Disease 2019 Vaccines Against Hospitalization and Death in Canada: A Multiprovincial, Test-Negative Design Study	37
Comparing Generative Artificial Intelligence vs Experts for Detection of Catheter-Associated Urinary Tract Infection	37
Management of Diarrhea in Young Children in Sub-Saharan Africa: Adherence to World Health Organization Recommendations During the Global Enteric Multisite Study (2007–2011) and the Vaccine Impact of D	37
Impact of Vaginal Estradiol on the Genitourinary Syndrome of Menopause, Vaginal Microbiome and Mucosal Immune Mediators in Women With HIV	36
The Dynamic Impact of Community Social Vulnerability on COVID-19 Outcomes: A Census Tract-level Analysis of Fulton County, Georgia	36
An Ensemble Framework for Projecting the Impact of Lymphatic Filariasis Interventions Across Sub-Saharan Africa at a Fine Spatial Scale	36
Environmental Testing of Surfaces in the Room of a Patient With Mpox	36
Fever and Extensive Blistering in a Patient With Atopic Dermatitis	36
Development and Clinical Evaluation of a Novel Talaromyces marneffei Mp1p Lateral Flow Assay for Rapid Diagnosis of Talaromycosis	36
Invasive Fungal Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in China: A Multicenter Epidemiological Study (CAESAR 2.0)	36
Is Higher Adherence Required for Women Using Oral Emtricitabine/Tenofovir Disoproxil Fumarate for Human Immunodeficiency Virus Preexposure Prophylaxis?	36
Questions About the 2023 Infective Endocarditis Updated Criteria	36
Put the Fluoroquinolone Down and No One Gets Hurt	36
Reassessing Adherence Trajectories in Multidrug-Resistant Tuberculosis: Recovery Advantage and Hidden Biases	36
Low CD4+ Cell Counts Linked to Mortality Rate After Sustained Virological Response: Evaluating Interaction With Liver Stiffness Versus the Fibrosis-4 Score	36
Applying Desirability of Outcome Ranking End Points	36
Collaborative Strategies for Antimicrobial Stewardship Programs: Navigating Financial and Regulatory Landscapes	36
Cardiovascular Outcomes After Tixagevimab and Cilgavimab use for Pre-Exposure Prophylaxis Against Coronavirus Disease 2019: A Population-Based Propensity-matched Cohort Study	36
It Takes Two to Transplant	35
Efficacy and Tolerability of Concomitant Use of Bedaquiline and Delamanid for Multidrug- and Extensively Drug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis	35
Reassessing the 2023 International Society for Cardiovascular Infectious Diseases Duke Clinical Criteria for Infective Endocarditis: Impact of Excluding Fever and Updating Diagnostic Definitions	35
Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE)	35
Duration of Effective Tuberculosis Treatment, Not Acid-Fast Bacilli (AFB) Smear Status, as the Determinant for De-isolation in Community Settings	35
Risk of Psychiatric Disorders, Use of Psychiatric Hospitals, and Receipt of Psychiatric Medication in Patients With Brain Abscess in Denmark	35
New Strategies for a Vexing Problem: Injectables to the Rescue for People With Multidrug-Resistant HIV	35
Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug Price	35
Impact of Clinician Feedback Reports on Antibiotic Use in Children Hospitalized With Community-acquired Pneumonia	35
Febrile Phase Soluble Urokinase Plasminogen Activator Receptor and Olfactomedin 4 as Prognostic Biomarkers for Severe Dengue in Adults	35
Efficacy of Primaquine for the Radical Cure of Plasmodium vivax Malaria in Northeast Myanmar and the Impact of Cytochrome P450 2D6 Genotypes	35
Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial Sexually Transmitted Infections: A Secondary Analysis of HPTN 083	35
Immunogenicity, Reactogenicity, and Safety of a Pentavalent Meningococcal ABCWY Vaccine in Adolescents and Young Adults Who Had Previously Received a Meningococcal ACWY Vaccine: A Phase 3, Randomized	34
Microbiology Laboratory Testing Practices of Gram-Negative Bloodstream Infections With Difficult-to-Treat Resistant Phenotypes in US Hospitals	34
Performance of Diagnostic Algorithms in Patients With Invasive Pulmonary Aspergillosis	34
Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 From Adult Index Cases With and Without Human Immunodeficiency Virus in South Africa, 2020–2021: A Case-Ascertained, Prospecti	34
The Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge—Implications for Health Services Implementation	34
Real World Virologic Outcomes in Patients With Elevated Body Mass Index Receiving Long Acting Cabotegravir/Rilpivirine	34
A Human Immunodeficiency Virus Type 1 Risk Assessment Tool for Women Aged 15–49 Years in African Countries: A Pooled Analysis Across 15 Nationally Representative Surveys	34
Pleural Empyema: Etiology and Pathogenesis	34
Transfer of Herpes Simplex Virus Type 1 (HSV-1) Specific T Cells in a Pediatric Patient Post-HSCT With Severe, Acyclovir-resistant HSV-1 Infection	34
Centering AIDS Drug Assistance Programs in the US HIV Response	33
The Frequency and Incidence of QT Prolongation With Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country Multidrug-Resistant/Rifampicin-Resistant Tuberculosis Cohort	33
Future Prospects for Using Clinical Phenotypes in Tuberculosis Precision Medicine—An Approach for Clinical Management	33
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study	33
Vaccine-Preventable Disease Outbreaks Among Healthcare Workers: A Scoping Review	33
Correct Calculation of Confidence Interval for Proportion of Superior Comparisons Between Desirability of Outcome Ranking Scores	33
Tuberculosis Infection Screening Recommendations for Targeted Immunotherapies: Comparison of US Prescribing Information, Clinical Resources, and Quality Measures	33
Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Intravenous Human Immunoglobulins Neutralizes Omicron Subvariants BA.1, BA.2, BA.2.12.1, BA.3, and BA.4/BA.5 for Treatment of Coronavirus Di	32
Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine	32
Right Antibiotic, Right Discharge: Ethical Tensions Between Antimicrobial Stewardship and Social Vulnerability	32
Cholesterol Contributes to Risk, Severity, and Machine Learning-Driven Diagnosis of Lyme Disease	32
Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Introduction and Methods	32
Emulating a Target Trial of Shorter Compared to Longer Course of Antibiotic Therapy for Gram-Negative Bacteremia	32
Temporal Trends in Hepatitis C–Related Hospitalizations, United States, 2000–2019	32
Demise of the Milwaukee Protocol for Rabies	32
Current Epidemiology and Clinical Features of Cryptococcus Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New Zealand	32
Immunogenicity, Reactogenicity, and Safety of AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein-based Candidate Vaccine (RSVPreF3 OA) When Co-administered With a Seasonal Quadriva	32
Reference Susceptibility Testing and Genomic Surveillance ofClostridioides difficile, United States, 2012–17	32
Barriers to Uptake of Long-Acting Antiretroviral Products for Treatment and Prevention of Human Immunodeficiency Virus (HIV) in High-Income Countries	32
HIV, HIV-Specific Factors, and Myocardial Disease in Women	32
Assessment of an Infectious Disease eConsult Service at a Large Mid-Atlantic Healthcare System	31
In the Literature	31
Reply to Bulloch	31
Antibiotic Indications and Appropriateness in the Pediatric Intensive Care Unit: A 10-Center Point Prevalence Study	31
In the Literature	31
A Woman With a Complex Cystic Pelvic Mass	31
Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019	31
Correction to: Assessment of an Infectious Disease eConsult Service at a Large Mid-Atlantic Healthcare System	31
Updating the Diagnostic Criteria for Infective Endocarditis: Time for a (Valve) Replacement	31
Correction to: The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe	31